TheodorePaulNicolaidesMD

Assistant Professor, Pediatrics, University of California, San Francisco, School of Medicine

Dr. Nicolaides is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2004 - 2007
NYU Grossman School of MedicineResidency, Pediatrics, 2001 - 2004
New York University School of MedicineClass of 2001

PubMed

Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.
Shashwat Tripathi, Hinda Najem, Corey Dussold, Sebastian Pacheco, Ruochen Du
The Journal of Clinical Investigation. 2024-08-13
Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment ofV600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-O...
Divya Ramakrishnan, Sarah C Brüningk, Marc von Reppert, Fatima Memon, Nazanin Maleki
AJNR. American Journal of Neuroradiology. 2024-04-08
2 citations
Sex differences in glioblastoma response to treatment: Impact of MGMT methylation.
Gino Cioffi, Kristin A Waite, Mantas Dmukauskas, Michael Glantz, Sonikpreet Aulakh
Neuro-Oncology Advances. 2024-03-01

New Mutations Enable Gliomas to Resist Proven Treatment, Study ShowsSeptember 24th, 2021
For Children with Brain Tumors, Next-Generation Sequencing May Lead to Different Diagnoses, Less Toxic Targeted TreatmentsNovember 16th, 2016